Method of using 2-[N-(2,6-dichloro-phenyl)-N-allyl-amino]-2-imidazoline and salts thereof as bradycardiacs

US4271175A · kind A · utility

Assignee

• Boehringer Ingelheim GmbH · DE

Inventors

• Helmut Stahle
• Herbert Koppe · Ingelheim am Rhein, DE
• Werner Kummer · Ingelheim am Rhein, DE
• Dietrich Arndts · Appenheim, DE
• Walter Kobinger · Wien, AT
• Christian Lillie · Wien, AT
• Ludwig Pichler · Wien, AT

Key dates

• Filing date: Jul 9, 1979
• Grant date: Jun 2, 1981
• Expiry date: Jul 9, 1999

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P9/10
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The method of using 2-[N-2,6-Dichloro-phenyl)-N-allyl-amino]-2-imidazoline or a non-toxic acid addition salt thereof as bradycardiacs.